These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34455777)

  • 41. Microbial transformation of trichostatin A to 2,3-dihydrotrichostatin A.
    Park JW; Park SR; Han AR; Ban YH; Yoo YJ; Kim EJ; Kim E; Yoon YJ
    J Nat Prod; 2011 May; 74(5):1272-4. PubMed ID: 21504214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quinazolin-4(3H)-one-Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
    Hieu DT; Anh DT; Hai PT; Thuan NT; Huong LT; Park EJ; Young Ji A; Soon Kang J; Phuong Dung PT; Han SB; Nam NH
    Chem Biodivers; 2019 Apr; 16(4):e1800502. PubMed ID: 30653817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tetrapeptides possessing a unique skeleton, JBIR-34 and JBIR-35, isolated from a sponge-derived actinomycete, Streptomyces sp. Sp080513GE-23.
    Motohashi K; Takagi M; Shin-Ya K
    J Nat Prod; 2010 Feb; 73(2):226-8. PubMed ID: 20146504
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why Hydroxamates May Not Be the Best Histone Deacetylase Inhibitors--What Some May Have Forgotten or Would Rather Forget?
    Shen S; Kozikowski AP
    ChemMedChem; 2016 Jan; 11(1):15-21. PubMed ID: 26603496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. JBIR-56 and JBIR-57, 2(1H)-pyrazinones from a marine sponge-derived Streptomyces sp. SpD081030SC-03.
    Motohashi K; Inaba K; Fuse S; Doi T; Izumikawa M; Khan ST; Takagi M; Takahashi T; Shin-ya K
    J Nat Prod; 2011 Jul; 74(7):1630-5. PubMed ID: 21728289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utilization of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidinone as a cap moiety in design of novel histone deacetylase inhibitors.
    Mohamed MFA; Youssif BGM; Shaykoon MSA; Abdelrahman MH; Elsadek BEM; Aboraia AS; Abuo-Rahma GEA
    Bioorg Chem; 2019 Oct; 91():103127. PubMed ID: 31374527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A phenylacetylated peptide, JBIR-96, isolated from Streptomyces sp. RI051-SDHV6.
    Ueda JY; Izumikawa M; Kozone I; Yamamura H; Hayakawa M; Takagi M; Shin-ya K
    J Nat Prod; 2011 May; 74(5):1344-7. PubMed ID: 21491925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents.
    He R; Chen Y; Chen Y; Ougolkov AV; Zhang JS; Savoy DN; Billadeau DD; Kozikowski AP
    J Med Chem; 2010 Feb; 53(3):1347-56. PubMed ID: 20055418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amide-based derivatives of β-alanine hydroxamic acid as histone deacetylase inhibitors: attenuation of potency through resonance effects.
    Liao V; Liu T; Codd R
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6200-4. PubMed ID: 22932316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cystargamides C and D, New Cyclic Lipopeptides From a Tidal Mudflat-Derived
    Seo J; Shin YH; Jo SJ; Du YE; Um S; Kim YR; Moon K
    Front Microbiol; 2022; 13():904954. PubMed ID: 35633690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural Requirements of Histone Deacetylase Inhibitors: SAHA Analogs Modified on the Hydroxamic Acid.
    Bieliauskas AV; Weerasinghe SV; Negmeldin AT; Pflum MK
    Arch Pharm (Weinheim); 2016 May; 349(5):373-82. PubMed ID: 27062198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors.
    Tischler JL; Abuaita B; Cuthpert SC; Fage C; Murphy K; Saxe A; Furr EB; Hedrick J; Meyers J; Snare D; Zand AR
    J Enzyme Inhib Med Chem; 2008 Aug; 23(4):549-55. PubMed ID: 18608778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.
    Cai J; Wei H; Hong KH; Wu X; Cao M; Zong X; Li L; Sun C; Chen J; Ji M
    Eur J Med Chem; 2015; 96():1-13. PubMed ID: 25874326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of aminophenylhydroxamate and aminobenzylhydroxamate derivatives and in vitro screening for antiparasitic and histone deacetylase inhibitory activity.
    Loeuillet C; Touquet B; Oury B; Eddaikra N; Pons JL; Guichou JF; Labesse G; Sereno D
    Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):59-66. PubMed ID: 29414107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design of N-substituted amino caproic hydroxamic acid histone deacetylase inhibitors reveal an essential role for cap atomic composition.
    Brunel JM; Salmi-Smail C; Restouin A; Prebet T; Vey N; Collette Y
    Anticancer Agents Med Chem; 2012 Sep; 12(7):801-6. PubMed ID: 22263799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel hydroxamic acid-containing antibiotic produced by a Saharan soil-living Streptomyces strain.
    Yekkour A; Meklat A; Bijani C; Toumatia O; Errakhi R; Lebrihi A; Mathieu F; Zitouni A; Sabaou N
    Lett Appl Microbiol; 2015 Jun; 60(6):589-96. PubMed ID: 25754683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A hybrid of thiazolidinone with the hydroxamate scaffold for developing novel histone deacetylase inhibitors with antitumor activities.
    Yang F; Peng S; Li Y; Su L; Peng Y; Wu J; Chen H; Liu M; Yi Z; Chen Y
    Org Biomol Chem; 2016 Feb; 14(5):1727-35. PubMed ID: 26732459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations.
    Kollar J; Frecer V
    J Mol Graph Model; 2018 Oct; 85():97-110. PubMed ID: 30145395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents.
    Cai J; Wei H; Hong KH; Wu X; Zong X; Cao M; Wang P; Li L; Sun C; Chen B; Zhou G; Chen J; Ji M
    Bioorg Med Chem; 2015 Jul; 23(13):3457-71. PubMed ID: 25953722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cystargamide B, a cyclic lipodepsipeptide with protease inhibitory activity from Streptomyces sp.
    Kitani S; Yoshida M; Boonlucksanawong O; Panbangred W; Anuegoonpipat A; Kurosu T; Ikuta K; Igarashi Y; Nihira T
    J Antibiot (Tokyo); 2018 Jul; 71(7):662-666. PubMed ID: 29567952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.